Live·Open questions in longevity research
Hypothesis Universe
Omega Point · Hypothesis

upkeep, and cell removal may independently extend life

in surviving , in living and may each yield lasting functional and lifespan gains; loss of a branch's distinct benefit when the other processes are constrained would reject their independence.

Stage of verification

  1. Hypothesis published2026-09-30
  2. Indirect evidenceAssessed at 4 of 10
  3. Direct testAwaited

Map of the hypothesis

Hover over an icon or tap it to see its name.

Where in the body

Main connectionWhole body

Ageing mechanism

Main connectionCellular senescence

Direction

Kind of knowledge gap

No current scientific result answers this requirement.Void gap

A double ring marks the main placement where a group contains several values.

Lens
Candidate set selection
Goal
Перечень причинно самостоятельных идей серебряных пуль для продления жизни
Competing hypotheses
3
Published
2026-09-30
As a hypothesis
7 / 10Clarity of mechanism
8 / 10Few extra conditions
10 / 10Completeness of the answer
6 / 10Novelty of the idea
7 / 10Few new entities
8 / 10Decisive experiment
4 / 10Silver-bullet potential
4 / 10Support from research
Poster: Cellular interventions independently extend lifespan
PosterOpen the sheet full size2026-10-01

Target map

Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.

  1. Rhythm or programme

    maintenance

    The processes that maintain cellular

    Where this hypothesis acts in surviving

    Hypotheses on this target 1
    Organelle maintenanceInhibition. Hypotheses on this target 0Activation. Hypotheses on this target 0Function preservation. Hypotheses on this target 11Feedback restoration. Hypotheses on this target 0Rhythm restoration. Hypotheses on this target 0Direct measurement. Hypotheses on this target 0
    • Inhibition
    • Activation
    • Function preservation1
    • Feedback restoration
    • Rhythm restoration
    • Direct measurement

    What is proposed

    Function preservation

    Support maintenance

    With whatNot stated in the record

    HowNot stated in the record

    Possible result

    Possible lasting functional benefits across multiple systems and increased lifespan

    From the recordM обслуживает органеллы сохраняющихся паренхиматозных клеток.

  2. Senescent cell

    in a senescent state

    Where this hypothesis actsLiving producing harmful

    Hypotheses on this target 7
    Senescent fibroblastsFunction preservation. Hypotheses on this target 22Senolysis. Hypotheses on this target 22Senomorphic suppression. Hypotheses on this target 11Clearance restoration. Hypotheses on this target 11Reprogramming. Hypotheses on this target 0Population balance. Hypotheses on this target 0
    • Function preservation2
    • Senolysis2
    • Senomorphic suppression1
    • Clearance restoration1
    • Reprogramming
    • Population balance

    What is proposed

    Senomorphic suppression

    Suppress harmful from

    With whatNot stated in the record

    HowSuppress while keeping the alive; the specific technique is not stated

    Possible result

    Possible improved function and survival even with and numbers held constant

    From the recordR уменьшает вредную секрецию живых сенесцентных фибробластов.

  3. Senescent cell

    Cells in a senescent state

    Where this hypothesis acts that impair tissue repair even when their is suppressed

    Hypotheses on this target 4
    Senescent cellsFunction preservation. Hypotheses on this target 11Senolysis. Hypotheses on this target 33Senomorphic suppression. Hypotheses on this target 0Clearance restoration. Hypotheses on this target 0Reprogramming. Hypotheses on this target 0Population balance. Hypotheses on this target 0
    • Function preservation1
    • Senolysis3
    • Senomorphic suppression
    • Clearance restoration
    • Reprogramming
    • Population balance

    What is proposed

    Senolysis

    Remove that impair tissue repair

    With whatNot stated in the record

    HowUse requiring by the

    Possible result

    Possible lasting functional benefits across multiple systems and increased lifespan

    From the recordуспешное C требует представления антигенов сенесцентными клетками и антиген-зависимой цитотоксичности.

All targets of the lab

Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.

MoleculesAntibodies. Hypotheses on this target 3AntibodiesInterleukin-1α. Hypotheses on this target 3Interleukin-1αAmyloid seeds. Hypotheses on this target 2Amyloid seedsATP. Hypotheses on this target 2ATPCGRP. Hypotheses on this target 2CGRPHyaluronan. Hypotheses on this target 2HyaluronanInterleukin-1 receptor antagonist. Hypotheses on this target 2Interleukin-1 receptor antagonistInterleukin-6. Hypotheses on this target 2Interleukin-6Potassium. Hypotheses on this target 2PotassiumSpecialized pro-resolving lipid mediators. Hypotheses on this target 2Specialized pro-resolving lipid mediatorsAmmonia. Hypotheses on this target 1AmmoniaAntimicrobial peptides. Hypotheses on this target 1Antimicrobial peptidesBlood carbon dioxide. Hypotheses on this target 1Blood carbon dioxideBMP. Hypotheses on this target 1BMPCholesterol crystals. Hypotheses on this target 1Cholesterol crystalsCorticosterone. Hypotheses on this target 1CorticosteroneCryptic collagen ligands. Hypotheses on this target 1Cryptic collagen ligandsDKK1. Hypotheses on this target 1DKK1Double-stranded RNA. Hypotheses on this target 1Double-stranded RNAExtracellular electrolytes. Hypotheses on this target 1Extracellular electrolytesExtracellular histones. Hypotheses on this target 1Extracellular histonesFas ligand. Hypotheses on this target 1Fas ligandGlutamine. Hypotheses on this target 1GlutamineGlutathione. Hypotheses on this target 1GlutathioneHeavy chain–hyaluronan complexes. Hypotheses on this target 1Heavy chain–hyaluronan complexesHistamine. Hypotheses on this target 1HistamineInterleukin-10. Hypotheses on this target 1Interleukin-10Interleukin-22. Hypotheses on this target 1Interleukin-22Lipid A. Hypotheses on this target 1Lipid ALipid hydroperoxides. Hypotheses on this target 1Lipid hydroperoxidesM3 receptor autoantibodies. Hypotheses on this target 1M3 receptor autoantibodiesNAD+. Hypotheses on this target 1NAD+NKG2D ligands. Hypotheses on this target 1NKG2D ligandsNoggin. Hypotheses on this target 1NogginOxygen. Hypotheses on this target 1OxygenPeroxide. Hypotheses on this target 1PeroxidePGP-family peptides. Hypotheses on this target 1PGP-family peptidesPhenol-soluble modulins alpha (PSMα). Hypotheses on this target 1Phenol-soluble modulins alpha (PSMα)Phosphatidylserine. Hypotheses on this target 1PhosphatidylserinePlatelet-activating anti-PF4 immunoglobulin. Hypotheses on this target 1Platelet-activating anti-PF4 immunoglobulinProstaglandin E2. Hypotheses on this target 1Prostaglandin E2RNA–DNA hybrids. Hypotheses on this target 1RNA–DNA hybridsSenescent-cell secretions. Hypotheses on this target 1Senescent-cell secretionsSmall RNAs. Hypotheses on this target 1Small RNAsSoluble BCMA. Hypotheses on this target 1Soluble BCMAStratum corneum lipids. Hypotheses on this target 1Stratum corneum lipidsTacrolimus. Hypotheses on this target 1TacrolimusTGF-β1. Hypotheses on this target 1TGF-β1Tissue-binding antibodies. Hypotheses on this target 1Tissue-binding antibodiesTryptophan. Hypotheses on this target 1TryptophanTumstatin. Hypotheses on this target 1TumstatinVIP. Hypotheses on this target 1VIPWNT. Hypotheses on this target 1WNT
GenesRetroelements. Hypotheses on this target 3RetroelementsAcquired nuclear DNA. Hypotheses on this target 1Acquired nuclear DNAAntimicrobial protein coding sequences. Hypotheses on this target 1Antimicrobial protein coding sequencesExtrachromosomal DNA. Hypotheses on this target 1Extrachromosomal DNAHerpes simplex virus genomes. Hypotheses on this target 1Herpes simplex virus genomesHLA-II expression. Hypotheses on this target 1HLA-II expressionHormone-response regulatory variant combinations. Hypotheses on this target 1Hormone-response regulatory variant combinationsIFT88. Hypotheses on this target 1IFT88IRF4 half-site CpG methylation at the TGFB1 enhancer. Hypotheses on this target 1IRF4 half-site CpG methylation at the TGFB1 enhancerUV photolesions. Hypotheses on this target 1UV photolesions
Enzymes and receptorsProteases. Hypotheses on this target 7ProteasesEP2 receptor. Hypotheses on this target 5EP2 receptorGLS1. Hypotheses on this target 5GLS1YAP. Hypotheses on this target 5YAPmTOR. Hypotheses on this target 4mTORERK. Hypotheses on this target 3ERKFAK. Hypotheses on this target 2FAKGlutamine synthetase. Hypotheses on this target 2Glutamine synthetasemTORC1. Hypotheses on this target 2mTORC1Myosin. Hypotheses on this target 2MyosinNK1 receptor. Hypotheses on this target 2NK1 receptorp300. Hypotheses on this target 2p30012-lipoxygenase. Hypotheses on this target 112-lipoxygenaseAcid sphingomyelinase. Hypotheses on this target 1Acid sphingomyelinaseACOD1. Hypotheses on this target 1ACOD1Acyloxyacyl hydrolase. Hypotheses on this target 1Acyloxyacyl hydrolaseADAR1. Hypotheses on this target 1ADAR1AKT. Hypotheses on this target 1AKTAlpha-adrenergic receptors. Hypotheses on this target 1Alpha-adrenergic receptorsAMPK. Hypotheses on this target 1AMPKAntiproteases. Hypotheses on this target 1AntiproteasesApoptotic caspases. Hypotheses on this target 1Apoptotic caspasesβ-arrestin-2. Hypotheses on this target 1β-arrestin-2CAD. Hypotheses on this target 1CADCatalase. Hypotheses on this target 1CatalaseCathepsins. Hypotheses on this target 1CathepsinsCD1a. Hypotheses on this target 1CD1aCD40. Hypotheses on this target 1CD40CD45. Hypotheses on this target 1CD45CD47. Hypotheses on this target 1CD47Collagen IV. Hypotheses on this target 1Collagen IVCollagen VII. Hypotheses on this target 1Collagen VIIDermal collagen I and III triple helices. Hypotheses on this target 1Dermal collagen I and III triple helicesDNA polymerase theta. Hypotheses on this target 1DNA polymerase thetaEGFR. Hypotheses on this target 1EGFReIF2α. Hypotheses on this target 1eIF2αExecutioner caspases. Hypotheses on this target 1Executioner caspasesFactor XIII. Hypotheses on this target 1Factor XIIIFcγRIIa. Hypotheses on this target 1FcγRIIaFibrin. Hypotheses on this target 1FibrinFibronectin. Hypotheses on this target 1FibronectinFilamin C. Hypotheses on this target 1Filamin CFKBP12. Hypotheses on this target 1FKBP12FPR2/ALX receptor. Hypotheses on this target 1FPR2/ALX receptorβ-glucocerebrosidase. Hypotheses on this target 1β-glucocerebrosidaseGlucose-6-phosphate dehydrogenase. Hypotheses on this target 1Glucose-6-phosphate dehydrogenaseHCMV Fc-binding proteins. Hypotheses on this target 1HCMV Fc-binding proteinsHistones. Hypotheses on this target 1HistonesHsp70. Hypotheses on this target 1Hsp70HSPB1. Hypotheses on this target 1HSPB1Hyaluronan synthase 2. Hypotheses on this target 1Hyaluronan synthase 2Interleukin-10 receptor. Hypotheses on this target 1Interleukin-10 receptorIntestinal alkaline phosphatase. Hypotheses on this target 1Intestinal alkaline phosphataseKCC2. Hypotheses on this target 1KCC2LOX. Hypotheses on this target 1LOXM3 muscarinic receptor. Hypotheses on this target 1M3 muscarinic receptorMast-cell chymase. Hypotheses on this target 1Mast-cell chymaseMetabolic enzymes. Hypotheses on this target 1Metabolic enzymesMYC. Hypotheses on this target 1MYCMyeloperoxidase. Hypotheses on this target 1MyeloperoxidaseN-homocysteinylated circulating fibrinogen. Hypotheses on this target 1N-homocysteinylated circulating fibrinogenNeutrophil elastase. Hypotheses on this target 1Neutrophil elastaseNitric oxide synthase. Hypotheses on this target 1Nitric oxide synthaseNK3 receptor. Hypotheses on this target 1NK3 receptorNKG2D receptor. Hypotheses on this target 1NKG2D receptorNOTUM. Hypotheses on this target 1NOTUMORF2. Hypotheses on this target 1ORF2PAR1. Hypotheses on this target 1PAR1PCMT1. Hypotheses on this target 1PCMT1PD-1. Hypotheses on this target 1PD-1PD-L1. Hypotheses on this target 1PD-L1Peptide–MHC complexes. Hypotheses on this target 1Peptide–MHC complexesPhosphofructokinase. Hypotheses on this target 1PhosphofructokinasePIEZO1. Hypotheses on this target 1PIEZO1Prostaglandin E2 receptors. Hypotheses on this target 1Prostaglandin E2 receptorsRibosomes. Hypotheses on this target 1RibosomesRNase H1. Hypotheses on this target 1RNase H1SIRT6. Hypotheses on this target 1SIRT6TIM-4. Hypotheses on this target 1TIM-4TLR2. Hypotheses on this target 1TLR2TRPV4. Hypotheses on this target 1TRPV4TSG-6. Hypotheses on this target 1TSG-6V8 protease. Hypotheses on this target 1V8 proteaseZAKα. Hypotheses on this target 1ZAKα
CellsOvarian somatic cells. Hypotheses on this target 3Ovarian somatic cellsT cells. Hypotheses on this target 3T cellsCooperating dangerous cells in breast tissue. Hypotheses on this target 2Cooperating dangerous cells in breast tissueMacrophages. Hypotheses on this target 2MacrophagesSenescent stromal cells. Hypotheses on this target 2Senescent stromal cellsAdrenal zona fasciculata cells. Hypotheses on this target 1Adrenal zona fasciculata cellsAntigen-presenting cells. Hypotheses on this target 1Antigen-presenting cellsAPC-altered cells. Hypotheses on this target 1APC-altered cellsBasal cells. Hypotheses on this target 1Basal cellsCapillary mural cells. Hypotheses on this target 1Capillary mural cellsCD1a-reactive T cells. Hypotheses on this target 1CD1a-reactive T cellsCompeting cells. Hypotheses on this target 1Competing cellsCorticotrophs. Hypotheses on this target 1CorticotrophsDendritic cells. Hypotheses on this target 1Dendritic cellsDifferentiated cells. Hypotheses on this target 1Differentiated cellsDll1-positive secretory progenitors. Hypotheses on this target 1Dll1-positive secretory progenitorsEpithelial progenitor cells. Hypotheses on this target 1Epithelial progenitor cellsFibroadipogenic progenitor cells. Hypotheses on this target 1Fibroadipogenic progenitor cellsFibroblasts. Hypotheses on this target 1FibroblastsGroup 3 innate lymphoid cells. Hypotheses on this target 1Group 3 innate lymphoid cellsHepatocytes. Hypotheses on this target 1HepatocytesIntestinal epithelial cells. Hypotheses on this target 1Intestinal epithelial cellsLgr5-positive stem cells. Hypotheses on this target 1Lgr5-positive stem cellsMast cells. Hypotheses on this target 1Mast cellsMature absorptive epithelial cells. Hypotheses on this target 1Mature absorptive epithelial cellsMedullary thymic epithelial cells. Hypotheses on this target 1Medullary thymic epithelial cellsMesenchymal stromal cells. Hypotheses on this target 1Mesenchymal stromal cellsMyeloid-biased long-term hematopoietic stem cells. Hypotheses on this target 1Myeloid-biased long-term hematopoietic stem cellsMyeloid–tissue hybrid cells. Hypotheses on this target 1Myeloid–tissue hybrid cellsMyofibroblasts. Hypotheses on this target 1MyofibroblastsNeutrophils. Hypotheses on this target 1NeutrophilsNK cells. Hypotheses on this target 1NK cellsReparative cells. Hypotheses on this target 1Reparative cellsSenescent osteogenic cells. Hypotheses on this target 1Senescent osteogenic cellsStromal cells. Hypotheses on this target 1Stromal cellsThymic epithelial cells. Hypotheses on this target 1Thymic epithelial cellsTumor-reactive T cells. Hypotheses on this target 1Tumor-reactive T cellsSenescent fibroblasts. Hypotheses on this target 7Senescent fibroblastsSenescent cells. Hypotheses on this target 4Senescent cells
Tissues and matrixExtracellular matrix. Hypotheses on this target 11Extracellular matrixCollagen fibers. Hypotheses on this target 6Collagen fibersSkin tissue. Hypotheses on this target 4Skin tissueElastin–fibrillin network. Hypotheses on this target 3Elastin–fibrillin networkSubcutaneous adipose tissue. Hypotheses on this target 2Subcutaneous adipose tissueAntigen deposits. Hypotheses on this target 1Antigen depositsArterial resistance. Hypotheses on this target 1Arterial resistanceBasement membranes. Hypotheses on this target 1Basement membranesCell neighborhood geometry. Hypotheses on this target 1Cell neighborhood geometryCell surface geometry. Hypotheses on this target 1Cell surface geometryCorneocyte intercellular contacts. Hypotheses on this target 1Corneocyte intercellular contactsEpidermal mechanical stress. Hypotheses on this target 1Epidermal mechanical stressHyaluronan-proteoglycan matrix. Hypotheses on this target 1Hyaluronan-proteoglycan matrixMechanical prestress. Hypotheses on this target 1Mechanical prestressMotor units. Hypotheses on this target 1Motor unitsSensory axons. Hypotheses on this target 1Sensory axonsStratum corneum. Hypotheses on this target 1Stratum corneumStromal contacts. Hypotheses on this target 1Stromal contactsTendon tissue. Hypotheses on this target 1Tendon tissueTissue compression. Hypotheses on this target 1Tissue compressionTissue hydrostatic pressure. Hypotheses on this target 1Tissue hydrostatic pressureTissue mechanical relaxation spectrum. Hypotheses on this target 1Tissue mechanical relaxation spectrumVenous capacitance. Hypotheses on this target 1Venous capacitanceWet contact network between skin, clothing and bedding. Hypotheses on this target 1Wet contact network between skin, clothing and bedding
ProcessesEfferocytosis. Hypotheses on this target 8EfferocytosisSensory afferent activity. Hypotheses on this target 7Sensory afferent activityEpithelial barrier repair. Hypotheses on this target 6Epithelial barrier repairLipid peroxidation. Hypotheses on this target 6Lipid peroxidationProtein translation. Hypotheses on this target 6Protein translationCalcium phosphate mineral growth. Hypotheses on this target 4Calcium phosphate mineral growthInflammation resolution. Hypotheses on this target 4Inflammation resolutionInflammatory response. Hypotheses on this target 4Inflammatory responseVasomotor discharges. Hypotheses on this target 4Vasomotor dischargesActomyosin contraction. Hypotheses on this target 3Actomyosin contractionAntigen-receptor signaling. Hypotheses on this target 3Antigen-receptor signalingAntimicrobial immune functions. Hypotheses on this target 3Antimicrobial immune functionsCircadian phase distribution. Hypotheses on this target 3Circadian phase distributionMemory replay. Hypotheses on this target 3Memory replayMitophagy. Hypotheses on this target 3MitophagyScope inference. Hypotheses on this target 3Scope inferenceSleep continuity. Hypotheses on this target 3Sleep continuityThermal balance. Hypotheses on this target 3Thermal balanceTissue renewal timing. Hypotheses on this target 3Tissue renewal timingAntigen presentation. Hypotheses on this target 2Antigen presentationAntimicrobial memory. Hypotheses on this target 2Antimicrobial memoryAutophagy. Hypotheses on this target 2AutophagyBacteriophage replication. Hypotheses on this target 2Bacteriophage replicationBlood flow–sweat secretion synchrony. Hypotheses on this target 2Blood flow–sweat secretion synchronyBone remodeling. Hypotheses on this target 2Bone remodelingCell fusion. Hypotheses on this target 2Cell fusionCell proliferation. Hypotheses on this target 2Cell proliferationCell recruitment. Hypotheses on this target 2Cell recruitmentEndocrine fluctuations. Hypotheses on this target 2Endocrine fluctuationsFerroptosis. Hypotheses on this target 2FerroptosisGap junction communication. Hypotheses on this target 2Gap junction communicationOxidative capacity. Hypotheses on this target 2Oxidative capacityPolyploidization. Hypotheses on this target 2PolyploidizationPositional signaling. Hypotheses on this target 2Positional signalingTransepithelial water transport. Hypotheses on this target 2Transepithelial water transportAct-to-training handoff. Hypotheses on this target 1Act-to-training handoffActivator–inhibitor signaling. Hypotheses on this target 1Activator–inhibitor signalingAnabolism. Hypotheses on this target 1AnabolismAntibody–effector co-occupancy. Hypotheses on this target 1Antibody–effector co-occupancyAntigen cross-presentation. Hypotheses on this target 1Antigen cross-presentationAntigen processing. Hypotheses on this target 1Antigen processingAntimicrobial deployment–epithelial repair synchrony. Hypotheses on this target 1Antimicrobial deployment–epithelial repair synchronyAttention allocation. Hypotheses on this target 1Attention allocationAutomatic recommendation delivery. Hypotheses on this target 1Automatic recommendation deliveryAutonomic recovery. Hypotheses on this target 1Autonomic recoveryBacterial utilization of exogenous fatty acids. Hypotheses on this target 1Bacterial utilization of exogenous fatty acidsCalcium homeostasis. Hypotheses on this target 1Calcium homeostasisCalcium signal decoding. Hypotheses on this target 1Calcium signal decodingCandidate/source binding. Hypotheses on this target 1Candidate/source bindingCardiovagal baroreflex. Hypotheses on this target 1Cardiovagal baroreflexCargo-mediated pathogen transfer. Hypotheses on this target 1Cargo-mediated pathogen transferCathelicidin carbamylation. Hypotheses on this target 1Cathelicidin carbamylationCausal test-selection policy. Hypotheses on this target 1Causal test-selection policyCell competition. Hypotheses on this target 1Cell competitionCell-cycle entry. Hypotheses on this target 1Cell-cycle entryCell membrane repair. Hypotheses on this target 1Cell membrane repairCell survival signaling. Hypotheses on this target 1Cell survival signalingCellular–antibody response timing. Hypotheses on this target 1Cellular–antibody response timingCentrosome organization. Hypotheses on this target 1Centrosome organizationcGAS–STING signaling. Hypotheses on this target 1cGAS–STING signalingChromatin programme of chronic secretion. Hypotheses on this target 1Chromatin programme of chronic secretionCoagulation cascade. Hypotheses on this target 1Coagulation cascadeCollagen crosslinking. Hypotheses on this target 1Collagen crosslinkingColonocyte metabolism. Hypotheses on this target 1Colonocyte metabolismCommunicative planning. Hypotheses on this target 1Communicative planningCommunity-conditioned modification of reconstruction. Hypotheses on this target 1Community-conditioned modification of reconstructionCompeting action accessibility. Hypotheses on this target 1Competing action accessibilityCompetitive drug displacement. Hypotheses on this target 1Competitive drug displacementComplement cascade. Hypotheses on this target 1Complement cascadeConcurrent incompatible-update reconciliation. Hypotheses on this target 1Concurrent incompatible-update reconciliationConvention compatibility. Hypotheses on this target 1Convention compatibilityCue-to-intention binding. Hypotheses on this target 1Cue-to-intention bindingCulture-to-risk feedback. Hypotheses on this target 1Culture-to-risk feedbackCutaneous vasodilation. Hypotheses on this target 1Cutaneous vasodilationDefault-preserving meta-choice. Hypotheses on this target 1Default-preserving meta-choiceDNA integration. Hypotheses on this target 1DNA integrationDNA repair. Hypotheses on this target 1DNA repairDNA replication licensing. Hypotheses on this target 1DNA replication licensingEnactment-cost feedback. Hypotheses on this target 1Enactment-cost feedbackEndocrine–circadian phase relationship. Hypotheses on this target 1Endocrine–circadian phase relationshipEndothelium-dependent vasodilation. Hypotheses on this target 1Endothelium-dependent vasodilationEntity correspondence. Hypotheses on this target 1Entity correspondenceEpidermal sealing–dermal remodeling synchrony. Hypotheses on this target 1Epidermal sealing–dermal remodeling synchronyEpidermal turnover. Hypotheses on this target 1Epidermal turnoverER-selective autophagy. Hypotheses on this target 1ER-selective autophagyErythrocyte arrival timing. Hypotheses on this target 1Erythrocyte arrival timingExcitation–secretion coupling. Hypotheses on this target 1Excitation–secretion couplingExtracellular infectious particle stabilization. Hypotheses on this target 1Extracellular infectious particle stabilizationExtracellular vesicle clearance. Hypotheses on this target 1Extracellular vesicle clearanceFailure detection and handover. Hypotheses on this target 1Failure detection and handoverFibrinolysis. Hypotheses on this target 1FibrinolysisGlutamine–glutamate cycle. Hypotheses on this target 1Glutamine–glutamate cycleGYS1-NONO condensation. Hypotheses on this target 1GYS1-NONO condensationHexosamine biosynthesis. Hypotheses on this target 1Hexosamine biosynthesisHistone export. Hypotheses on this target 1Histone exportHorizontal nuclear DNA transfer. Hypotheses on this target 1Horizontal nuclear DNA transferHost oxidant production. Hypotheses on this target 1Host oxidant productionIgG Fc glycosylation. Hypotheses on this target 1IgG Fc glycosylationImmune surveillance. Hypotheses on this target 1Immune surveillanceImmune target discrimination. Hypotheses on this target 1Immune target discriminationInstruction-scope conversion. Hypotheses on this target 1Instruction-scope conversionInterpretation switching. Hypotheses on this target 1Interpretation switchingIntracellular protein clearance. Hypotheses on this target 1Intracellular protein clearanceKeratinocyte polarity. Hypotheses on this target 1Keratinocyte polarityLymphocyte–APC contact timing. Hypotheses on this target 1Lymphocyte–APC contact timingLysosomal membrane permeabilization. Hypotheses on this target 1Lysosomal membrane permeabilizationLysosomal peptidoglycan degradation. Hypotheses on this target 1Lysosomal peptidoglycan degradationLysosome reformation. Hypotheses on this target 1Lysosome reformationMacromolecular crowding. Hypotheses on this target 1Macromolecular crowdingMeal–activity timing. Hypotheses on this target 1Meal–activity timingMechanical interference among lymphocytes. Hypotheses on this target 1Mechanical interference among lymphocytesMechanical load–mitosis timing. Hypotheses on this target 1Mechanical load–mitosis timingMechanical loading. Hypotheses on this target 1Mechanical loadingMechanoradical production. Hypotheses on this target 1Mechanoradical productionMental accounting. Hypotheses on this target 1Mental accountingMicrobial chemical defense. Hypotheses on this target 1Microbial chemical defenseMitochondrial fusion. Hypotheses on this target 1Mitochondrial fusionMitochondrial maintenance. Hypotheses on this target 1Mitochondrial maintenanceMitochondrial proton leak. Hypotheses on this target 1Mitochondrial proton leakMitochondrial transfer. Hypotheses on this target 1Mitochondrial transferMitosis. Hypotheses on this target 1MitosisMitotic entry in basal keratinocytes. Hypotheses on this target 1Mitotic entry in basal keratinocytesMitotic synchrony. Hypotheses on this target 1Mitotic synchronyMnemonic retention demand. Hypotheses on this target 1Mnemonic retention demandMuscle fiber adaptation. Hypotheses on this target 1Muscle fiber adaptationMutagenesis. Hypotheses on this target 1MutagenesisNeurogenic vasodilation. Hypotheses on this target 1Neurogenic vasodilationNeurokinin signaling. Hypotheses on this target 1Neurokinin signalingNeuronal secretion. Hypotheses on this target 1Neuronal secretionNF-κB activation. Hypotheses on this target 1NF-κB activationNitrogen-processing reaction network. Hypotheses on this target 1Nitrogen-processing reaction networkOxidative metabolism. Hypotheses on this target 1Oxidative metabolismParacrine signal–response synchrony. Hypotheses on this target 1Paracrine signal–response synchronyPartner retention and sorting. Hypotheses on this target 1Partner retention and sortingPathogen export. Hypotheses on this target 1Pathogen exportPeptide conjugation. Hypotheses on this target 1Peptide conjugationPeroxide clearance. Hypotheses on this target 1Peroxide clearancePlatelet adhesion. Hypotheses on this target 1Platelet adhesionPost-injury illness cascades. Hypotheses on this target 1Post-injury illness cascadesPreference construction. Hypotheses on this target 1Preference constructionPrimary cilium assembly. Hypotheses on this target 1Primary cilium assemblyProspective time allocation. Hypotheses on this target 1Prospective time allocationProtein carbamylation. Hypotheses on this target 1Protein carbamylationPublic commitment to cultural propositions. Hypotheses on this target 1Public commitment to cultural propositionsReceptor signal integration. Hypotheses on this target 1Receptor signal integrationReciprocal phase resetting. Hypotheses on this target 1Reciprocal phase resettingRegeneration–immune recognition timing. Hypotheses on this target 1Regeneration–immune recognition timingRegulatory-cell cytotoxicity. Hypotheses on this target 1Regulatory-cell cytotoxicityRelational memory. Hypotheses on this target 1Relational memoryRenal tubular reabsorption. Hypotheses on this target 1Renal tubular reabsorptionRibosome assembly. Hypotheses on this target 1Ribosome assemblyRNA splicing. Hypotheses on this target 1RNA splicingScratch contact. Hypotheses on this target 1Scratch contactScratch motor program. Hypotheses on this target 1Scratch motor programSemantic rewriting. Hypotheses on this target 1Semantic rewritingSensory integration. Hypotheses on this target 1Sensory integrationSkin adhesion. Hypotheses on this target 1Skin adhesionSkin barrier repair. Hypotheses on this target 1Skin barrier repairSolar radiation absorption. Hypotheses on this target 1Solar radiation absorptionSource-conditioned reconstruction. Hypotheses on this target 1Source-conditioned reconstructionSpatial coordination of ERK signaling. Hypotheses on this target 1Spatial coordination of ERK signalingStromal cell–matrix mechanical coupling. Hypotheses on this target 1Stromal cell–matrix mechanical couplingSweat evaporation. Hypotheses on this target 1Sweat evaporationThermoregulatory feedback. Hypotheses on this target 1Thermoregulatory feedbackTissue growth. Hypotheses on this target 1Tissue growthTissue renewal cycles. Hypotheses on this target 1Tissue renewal cyclesTissue repair. Hypotheses on this target 1Tissue repairTranscription. Hypotheses on this target 1TranscriptionTranscription-factor partnerships. Hypotheses on this target 1Transcription-factor partnershipsTranscription–replication conflicts. Hypotheses on this target 1Transcription–replication conflictsTranscriptional priming in estrogen-responsive cells. Hypotheses on this target 1Transcriptional priming in estrogen-responsive cellsTranscriptional repression. Hypotheses on this target 1Transcriptional repressionTransdermal drug absorption. Hypotheses on this target 1Transdermal drug absorptionTransmission timing. Hypotheses on this target 1Transmission timingtRNA queuosine modification. Hypotheses on this target 1tRNA queuosine modificationUbiquitin-dependent proteasomal degradation. Hypotheses on this target 1Ubiquitin-dependent proteasomal degradationVariant competition and selection. Hypotheses on this target 1Variant competition and selectionVascular obstruction. Hypotheses on this target 1Vascular obstructionOrganelle maintenance. Hypotheses on this target 1Organelle maintenance
Microbial communitiesGut microbiota. Hypotheses on this target 3Gut microbiotaBacterial pathogens. Hypotheses on this target 1Bacterial pathogens
MeasurementsCultural transmission mechanism classification. Hypotheses on this target 9Cultural transmission mechanism classificationMenopause syndrome classification. Hypotheses on this target 5Menopause syndrome classificationSweat secretory response. Hypotheses on this target 5Sweat secretory responseCircadian phase. Hypotheses on this target 2Circadian phaseCognitive performance measurements. Hypotheses on this target 2Cognitive performance measurementsNyquist stability boundary. Hypotheses on this target 2Nyquist stability boundaryRecovery status classification. Hypotheses on this target 2Recovery status classificationAntibody neutralizing activity. Hypotheses on this target 1Antibody neutralizing activityApplied shear load. Hypotheses on this target 1Applied shear loadCausal-binding accessibility. Hypotheses on this target 1Causal-binding accessibilityClone size measurement. Hypotheses on this target 1Clone size measurementContractile exit assessment. Hypotheses on this target 1Contractile exit assessmentFunctional performance measurements. Hypotheses on this target 1Functional performance measurementsInvasion measurement. Hypotheses on this target 1Invasion measurementMitotically reactivatable infected cell count. Hypotheses on this target 1Mitotically reactivatable infected cell countmt-Keima signal. Hypotheses on this target 1mt-Keima signalOptical oxygen saturation estimate. Hypotheses on this target 1Optical oxygen saturation estimatePerfusion measurements. Hypotheses on this target 1Perfusion measurementsSemantic coding. Hypotheses on this target 1Semantic codingSkin ageing index. Hypotheses on this target 1Skin ageing indexSkin microdamage classification. Hypotheses on this target 1Skin microdamage classificationSkin redness. Hypotheses on this target 1Skin rednessSkin water evaporation measurement. Hypotheses on this target 1Skin water evaporation measurementTarget-specific immune response measurements. Hypotheses on this target 1Target-specific immune response measurementsTreatment response classification. Hypotheses on this target 1Treatment response classificationViable pathogen burden. Hypotheses on this target 1Viable pathogen burden

Solid and named: the targets of this hypothesis

Explore in depth

The logic

The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.

The descent, in plain words

Longer life might come from several independently useful repairs, even when the processes that drive aging reinforce one another. The unexpected move is to make one repair depend on targeted immune recognition: removing troublesome cells is proposed to require those cells to display identifying fragments that allow immune cells to kill them. This is a hypothesis generated by the pipeline, not a measured finding.

The proposed mechanism, link by link
  1. In the first proposed route, maintenance of internal cell structures supports surviving tissue cells and independently improves lasting function and survival.
  2. In the second proposed route, reduced harmful release from living senescent connective-tissue cells independently improves function and survival while those cells remain present.
  3. In the third proposed route, cells continue to obstruct tissue repair even after their harmful release has been suppressed.
  4. Those obstructing cells display identifying molecular fragments that enable immune cells to recognize and kill them.
  5. Their removal relieves the proposed obstruction to repair and independently improves lasting function and survival.
A picture for it

A workshop can lose output because its tools are damaged, a machine leaks fumes, or an idle machine blocks the work area. Fixing the tools, stopping the fumes, and clearing the obstruction could each help while leaving the other problems in place.

Where the picture breaks: The picture assumes three separable problems. Whether the biological processes are separable, whether each improves lifespan, and whether removal requires immune recognition are precisely the claims still awaiting tests.

  1. Master questionstep 01 of 04

    Aging processes may reinforce one another, so acting on a shared cause could benefit several body systems at once.

    Rests on: The goal adopts the possibility that a shared cause connects otherwise different forms of age-related decline.

    Assumption

    The goal assumes that at least some interacting aging processes have a shared cause whose modification could produce benefits across several systems; it does not establish a particular cause.

  2. Goal pillarstep 02 of 04

    The intended output is a collection of life-extension ideas that work through genuinely different causes.

    Rests on: The master question requests ideas for interventions that could benefit several systems through a causal target.

    Stated in the chain
  3. Gap questionstep 03 of 04

    The number of distinct ideas would be determined by separately switching intervening processes off and restoring them, then checking which interventions retain distinct, lasting benefits for several systems and lifespan.

    Rests on: The preceding goal requires distinguishing ideas by their causes; this stage makes that distinction depend on controlled interruption and restoration of the proposed processes.

    Stated in the chain
  4. Hypothesisstep 04 of 04

    Three independent routes are proposed: maintaining , the working structures inside surviving tissue cells; reducing harmful , the release of substances, from living , connective-tissue cells in a persistent state of arrested division; and removing cells that obstruct repair even after their harmful is suppressed. The removal route is proposed to require , the display of identifying molecular fragments on a cell’s surface, and , immune killing directed by recognition of those fragments. Each route is predicted to provide a distinct functional and lifespan benefit that the other two cannot replace.

    Rests on: The chain’s requirement for separately interruptible benefits supplies the proposed independence test. The endpoint assigns a different causal role to each route and explicitly borrows its immune-recognition requirement from , the study of immune responses to cancer; that borrowing is a proposed dependency rather than evidence that it operates here.

    Stated in the chain

What is carried, and what is not. Screened sources address aspects of all three proposed routes, but not their independence: S1 in Redox Biology (2026) reports increased , the selective removal of mitochondria, cells’ energy-converting structures, alongside improved condition of aged heart muscle cells, without establishing longer life; S7 in Nature Communications (2026) reports that substances released by senescent human promoted cancer-cell growth, movement and invasion, without establishing an independent benefit from reducing that release during aging; and S9 in Aging (2011) describes delayed tissue disorders following removal of selected cells in mice with a premature-aging condition, without testing lifespan or the proposed immune-recognition requirement. No supplied source establishes the full sequence, three independently sufficient routes, or the claim that every pair misses a distinct functional and lifespan benefit.S1S7S9

Where the reasoning is carried by something unstated · 1
  • Master question. The goal assumes that at least some interacting aging processes have a shared cause whose modification could produce benefits across several systems; it does not establish a particular cause.
How a result here could mislead · 3
  • A survival gain after immune-mediated cell removal could reflect fewer cancer deaths rather than improved repair and function across aging tissues. What closes it: The organism-level test must distinguish causes of death and measure sustained function in several systems alongside survival. The supplied proposal explicitly excludes reduced cancer mortality alone from its success criterion.
  • An apparent independent benefit from reducing harmful release could actually come from increased mitochondrial removal or fewer if the supposedly fixed processes drift during the experiment. What closes it: The rate of mitochondrial removal and the number of must be measured throughout the relevant period, alongside harmful release, function and survival. Conditions for treating those quantities as fixed must be specified before interpreting the result; the supplied material gives no thresholds or verification schedule.
  • Loss of benefit after blocking molecular-fragment display could be attributed to failed cell removal even if the manipulation changes the target cells’ harmful behavior directly. Conversely, persistent benefit could appear to refute the dependency when display was never effectively blocked. What closes it: The test must verify loss and restoration of fragment display, measure recognition-dependent killing and actual cell removal, and check whether the manipulation changes harmful release or repair obstruction without removal. The proposed maintenance and -reduction interventions must also be assessed under the same conditions, as the prediction requires.

What would make this wrong. The three-route claim would fail if, with the intended changes verified and a common success criterion fixed in advance, one route provided no independent lasting functional and survival benefit when the other two processes were restricted. A particularly discriminating failure would be loss of the -reduction benefit when mitochondrial removal and number were successfully held fixed. The proposed immune dependency would separately fail if cell removal and its lasting benefit persisted despite verified suppression of target-cell . These outcomes would reject parts of this hypothesis without automatically establishing any one rival.

What it would change. If the hypothesis held, the search for broadly useful life-extension interventions would need to retain three causally distinct ideas within this candidate set: collapsing them into one shared repair process would discard independent benefits. Any pair would miss a reproducible benefit supplied by the third route. Even then, the supplied material does not specify the species, intervention identities, treatment duration or numerical success criteria for the decisive organism-level test, and a positive result in that system would not by itself establish longer human life or exhaust the possible targets.

Sources read · 10

3 literature searches, 6 full texts, 4 abstract-only; 10 source(s) assessed against this question using the available text. A bounded search is not evidence of absence.

S1Partly answers it

CHK1 activates mitophagy to attenuate cardiac aging via inhibiting AHSA1-ubiquitination. · Redox biology · 2026

“In our study, we observed that CHK1 overexpression in senescent cardiomyocytes robustly augmented mitophagy, resulting in reduced ROS accumulation, mitigation of ROS-induced DNA damage and apoptosis, improved mitochondrial respiratory efficiency, and normalization of aberrant mitochondrial morphology.”

Does not settle: Источник описывает поддержание качества митохондрий в сенесцентных кардиомиоцитах и эффекты в старых мышах. Он не устанавливает продление жизни, не рассматривает снижение вредной секреции живых сенесцентных фибробластов, удаление клеток, представление антигенов или антиген-зависимую цитотоксичность, а также не проверяет необходимость набора из трёх представителей.

S2Partly answers it

Tetrahydroberberrubine retards heart aging in mice by promoting PHB2-mediated mitophagy. · Acta pharmacologica Sinica · 2023

“We showed that BBR and THBru treatment significantly mitigated diastolic dysfunction and cardiac remodeling in D-gal-induced aging mice.”

Does not settle: Источник поддерживает только идею M в модели старения сердца у мышей и в неонатальных кардиомиоцитах мыши. Он не устанавливает продление жизни, применимость к сохраняющимся паренхиматозным клеткам в целом, идеи R и C, их независимость, достаточность трёх представителей или требование антигенного представления и антиген-зависимой цитотоксичности для C.

S3Partly answers itAbstract only

Astragalus polysaccharide alleviated hepatocyte senescence via autophagy pathway. · The Kaohsiung journal of medical sciences · 2022

“APS reduced reactive oxygen species levels, inhibited apoptosis and pyroptosis, and promoted mitophagy via AMPK/mTOR pathway to alleviate hepatocyte senescence in vitro and in vivo.”

Does not settle: Источник описывает поддержание митохондриального гомеостаза и уменьшение старения гепатоцитов в клеточных линиях и у старых мышей. Он не устанавливает продление жизни, независимость трёх идей, эффекты R или C, а также требование представления антигенов и антиген-зависимой цитотоксичности для удаления клеток.

S4Partly answers it

Alpha-ketoglutarate ameliorates pressure overload-induced chronic cardiac dysfunction in mice. · Redox biology · 2021

“These results suggest that AKG increased myocardial mitophagy and reduced ROS production and cellular apoptosis under pressure overload.”

Does not settle: Источник рассматривает АКГ при вызванной давлением сердечной дисфункции у мышей и кардиомиоцитов; он не устанавливает продление жизни, независимость трёх идей, эффекты на сенесцентные фибробласты или антиген-зависимое удаление клеток.

S5Contradicts it

Cellular senescence and acute kidney injury. · Pediatric nephrology (Berlin, Germany) · 2022

“Interestingly, genetic and pharmacological elimination of senescent cells partially prevents fibrosis but does not protect kidney function.”

Does not settle: Источник не устанавливает три независимые идеи, их минимальных представителей, влияние на продолжительность жизни, подавление секреции сенесцентных фибробластов или необходимость представления антигенов и антиген-зависимой цитотоксичности.

S6BackgroundAbstract only

Heart Failure: Lipid Metabolism Disorders Driving Cellular Senescence Through a Vicious Cycle, and Possible Intervention Strategies. · Frontiers in bioscience (Landmark edition) · 2026

“The senescence-associated secretory phenotype (SASP) promotes a pro-senescent tissue microenvironment, thereby disrupting the normal metabolic balance and creating a vicious cycle that seriously affects heart structure and function.”

Does not settle: Абстракт не устанавливает самостоятельные эффекты M, R и C на продолжительность жизни или функции, не описывает сенесцентные фибробласты, устранение клеток при подавленной секреции, представление антигенов или антиген-зависимую цитотоксичность.

S7Partly answers it

Time-resolved multiomics profiling reveals chromatin O-GlcNAc modification promotes senescence-associated transcriptional program. · Nature communications · 2026

“OIS-affected LU-RAS/KD-WT cells significantly stimulated the expansion, migration and invasion of A549 lung cancer cells through the secretion of SASP components.”

Does not settle: Источник показывает в модели сенесценции первичных человеческих фибробластов, что секреция компонентов секреторного фенотипа сенесцентных клеток стимулировала злокачественные свойства клеток A549. Он не устанавливает продление жизни, самостоятельный эффект вмешательства R на тканевое восстановление или старение, а также роли M и C, представления антигенов и антиген-зависимой цитотоксичности.

S8Partly answers itAbstract only

Senolytic Interventions Enhance the Anti-metastatic Activity of Chemotherapy in Prostate Cancer. · Cancer research · 2026

“Senolytic therapies targeting the pro-survival BCL2 and IAP pathways upregulated after docetaxel-induced senescence effectively killed senescent tumor cells through multiple cell death pathways, remodeling the inflammatory SASP to repolarize myeloid phenotypes and potentiate CD8+ T cell activation to further block tumor growth and suppress metastasis.”

Does not settle: This abstract concerns therapy-induced senescent prostate cancer cells in cell lines and mouse tumor models. It does not establish organelle maintenance in parenchymal cells, secretion reduction in senescent fibroblasts, removal of cells that impair tissue repair despite suppressed secretion, antigen presentation by senescent cells, antigen-dependent cytotoxicity, independent lifespan effects, or the sufficiency of three representatives.

S9Partly answers it

Metformin and the ATM DNA damage response (DDR): accelerating the onset of stress-induced senescence to boost protection against cancer. · Aging · 2011

“Using a BubR1 progeroid mouse background designed for inducible elimination of p16 Ink4a -positive senescent cells, the authors demonstrate that in tissues in which p16 Ink4a contributes to the acquisition of age-related pathologies (i.e., adipose tissue, skeletal muscle and eye), life-long removal of p16 Ink4a -expressing cells significantly delays onset of these pathologies.”

Does not settle: Источник описывает удаление p16 Ink4a-положительных клеток в прогероидной мышиной модели, но не устанавливает три независимые идеи или достаточность трёх представителей. Он не сообщает, что устранение клеток требует представления антигенов сенесцентными клетками либо антиген-зависимой цитотоксичности, и не проверяет подавленную секрецию, восстановление тканей или продолжительность жизни.

S10BackgroundAbstract only

From cancer immunosurveillance to cancer immunotherapy. · Immunological reviews · 2007

“We here discuss the immunological consequences of cellular senescence and apoptosis in the context of tumorigenesis.”

Does not settle: Аннотация не устанавливает, что сенесцентные клетки представляют антигены и что их устранение требует антиген-зависимой цитотоксичности. Она также не оценивает M, R или C, тканевое восстановление, продолжительность жизни либо достаточность набора из трёх представителей.

The gap this hypothesis explains

Nothing is known here: the question has not been asked of this system.

How many distinct ways of extending life remain when targets are tested by disabling and restoring shared biological steps?

Original wording · exactly as the pipeline generated it
The gap question, as the engine wrote it

Сколько причинно самостоятельных идей «» содержит проверяемый набор , если раздельное выключение и восстановление должно определить, какие воздействия остаются различимыми по длительной пользе нескольким системам и продолжительности жизни?

What this question is asking

The question concerns how many genuinely separate routes to longer life are represented by a collection of biological targets. It asks whether switching off and then restoring mediators—the biological steps through which an intervention produces its effects—can distinguish interventions by their lasting benefits across several body systems and their effects on lifespan. Interventions would be compared over the same long observation period, and renaming an intervention or combining equivalent descriptions would not change the count. The question assumes that these dependency tests can support such a count, while allowing that shared mediators and limits on the benefit available may make different interventions look equivalent. The supplied material does not identify the complete target collection or specify that common observation period.

What the terms mean
Biological target
A component or process that an intervention is intended to change. Different target names do not by themselves establish different routes to a benefit.
Intervention
A deliberate change, such as exercise, altered food intake, or disabling a gene, whose effects are assessed. Here, interventions are compared by their biological dependencies and lasting outcomes.
Mediator and biological dependency
A mediator is an intermediate biological step through which an intervention affects an outcome. An outcome depends on that step when disrupting it prevents the relevant effect in the tested setting; this does not establish that the step alone can produce the effect.
Disabling and restoration
Disabling reduces or removes a biological component's activity; restoration brings that component or its activity back. The question uses these changes to examine which effects depend on which steps.
Causally independent routes and causal equivalence
These describe whether interventions work through distinguishable chains of biological effects or can be grouped as the same route under a stated rule. They are proposed categories for counting, and the supplied material does not provide a complete rule for assigning them.
Ceiling on benefit
A limit beyond which a measured benefit no longer increases. Such a limit could make different interventions look similar, but its role in the intended target collection is not established.
Muscle stem cells and activation
Muscle stem cells are cells involved in maintaining and repairing muscle. Activation is their transition from a resting state toward activity involved in repair; S5 concerns their ability to make that transition in old mice.
Cyclin D1
A protein involved in controlling a cell's progression toward division. S5 identifies its restoration as necessary for recovery of the muscle stem-cell activation ability described there.
Genes and genetically altered model
Genes are inherited instructions that influence biological functions. A genetically altered model is an organism with an inherited change used to study a process; S6 concerns a particular worm model rather than all forms of reduced food intake.
Autophagy
A group of processes through which cells break down and recycle their own material. S6 concerns the requirement for this activity in the intestine in one worm lifespan model.
Dietary restriction
Reduced food intake or availability relative to a comparison condition. It covers different experimental arrangements; S6 concerns one genetic model of it.
Insulin sensitivity
How strongly the body responds to insulin, a hormone that helps regulate blood sugar. S8 measures changes in this response rather than lifespan.
Oxygen-dependent metabolism
The chemical processes through which cells use oxygen to help obtain energy. S8 reports indicators of these processes, which are measurements of selected features rather than a complete account of how the interventions work.
Littermates
Animals born in the same litter. The supplied S7 excerpt uses such animals as the comparison for mice lacking the candidate target.
What the question takes for granted
Premise only partly supported
Separate disabling and restoration of mediators can determine which interventions remain causally distinguishable by long-term benefits across several systems and lifespan, allowing a count that is unchanged by renaming or combining equivalent descriptions.

A mediator is a biological step between an intervention and its effects; disabling it tests whether an effect depends on that step, while restoring it examines whether the effect returns. The question assumes that these tests can sort a collection of interventions into genuinely different ways of producing lasting benefits and longer life. If that assumption holds, the count would reflect biological differences rather than the number of labels attached to targets.

S5 reports that recovery of activation ability in old mouse muscle stem cells depends on restoration of Cyclin D1. S6 reports that inhibiting cellular recycling in the intestine prevents the long lifespan of a particular worm model of restricted food intake. These support narrower claims about dependence on particular biological steps. Neither establishes a method for counting independent routes across a complete target collection using both disabling and restoration, a shared long-term comparison, benefits across several systems, and lifespan.S5S6

The same question asked without the part nothing read establishes:

  • Which interventions in the target collection remain distinguishable in lasting benefits across several body systems and lifespan after shared biological steps are disabled and restored?
  • What do the read sources establish about whether the candidate interventions depend on the same biological steps for their benefits?
What turns on the answer
  • Several targets reduce to fewer routes If the dependency tests showed that differently named interventions produced their lasting benefits through the same route, those names would not establish separate opportunities to extend life. Treating every target as independent would then overcount the possibilities under the question's proposed counting rule.
  • Several routes remain distinguishable If interventions retained different dependencies and different lasting effects after the tests, combining their descriptions would conceal biological differences. Under the question's proposed rule, those distinguishable routes would count separately.
  • The tests leave the count unresolved If shared steps or a ceiling on measurable benefit made different routes produce indistinguishable results, the tests would not uniquely determine the count. An apparent match in outcomes would then leave open whether the interventions were equivalent or whether the comparison could not distinguish them.
Why it matters

An intervention may affect a target, which changes a mediator, which then changes how a body system functions. If several interventions depend on the same mediator, counting their names separately could overstate the number of independent opportunities to extend life. Conversely, similar measured benefits do not establish that the interventions work through the same route. Mistaking short-term improvement in one tissue for lasting benefits across several systems would also assign an intervention a broader effect than the supplied findings establish.

What is already established

S-узлы описывают клеточные и иммунные механизмы уровней RL-1 и RL-2; метод проверки зависимостей доступен, не подсчитаны.

What would have to be true

Число самостоятельных идей, устойчивое к переименованию и объединению эквивалентных описаний, с различимыми прогнозами на общем .

What is missing

Число названных неизвестным образом соотносится с числом самостоятельных возможностей продления жизни; общие и могут скрывать различия.

The mechanism it proposes

The engine's own statement of the hypothesis, in full.

В наборе содержатся три самостоятельные идеи с {}, {} и {}; имеет вид {{},{},{}}. обслуживает сохраняющихся . уменьшает вредную живых . устраняет клетки, нарушающие даже при подавленной . Неожиданная необходимая зависимость третьей идеи заимствована из : успешное требует и . Три представителя достаточны для охвата трёх независимых ответов; любой набор из двух пропускает один функциональный и жизненный выигрыш.

Testing and possible results

The prediction that would tell it apart

A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.

Каждое одиночное воздействие проходит общий и сохраняет часть пользы при специфическом ограничении двух других процессов. Для подавление устраняет удаление клеток и длительный эффект; возврат восстанавливает оба результата. и сохраняют пользу в тех же условиях. Особенно различающий результат: улучшает функции и выживаемость при экспериментально фиксированных и числе .

Would tell it apart from at least one rival. The prediction specifies observable loss and restoration of effects, retained benefit under the same conditions, and improved function and survival with two processes held fixed. No rival prediction is supplied. Only a bench experiment would settle it.

What testing it would take

The engine's own read on whether this is testable with methods that already exist.

и можно измерять в . В организме нужно отделять удаление от : снижение только при отсутствии не удовлетворяет .

Other explanations

Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.

This hypothesis predicts

Каждое одиночное воздействие проходит общий и сохраняет часть пользы при специфическом ограничении двух других процессов. Для подавление устраняет удаление клеток и длительный эффект; возврат восстанавливает оба результата. и сохраняют пользу в тех же условиях. Особенно различающий результат: улучшает функции и выживаемость при экспериментально фиксированных и числе .

  • What would separate them

    Restoring mitochondrial renewal may account for all lasting benefits of the tested interventions predicts: При подтверждённом удалении и снижении их мягкое выключение только в сохраняющихся полностью устраняет длительную пользу и . Возврат восстанавливает пользу. Напротив, изолированное сохраняет функциональный и жизненный выигрыш при экспериментальном удержании числа и их около исходного уровня. Такой результат отличает единственный достаточный элемент {} от двух независимых элементов, трёх независимых элементов и обязательной комбинации.

  • What would separate them

    Organelle renewal and senescent cell clearance may provide independent lasting benefits predicts: После выравнивания завершённого перестаёт давать дополнительный длительный эффект. сохраняет пользу при умеренном специфическом снижении ; сохраняет пользу при снижении . Возврат соответствующего восстанавливает только его ветвь. переработки материала показывает два независимо изменяемых . В отличие от гипотезы 01, способен приносить пользу при ограниченном ; в отличие от гипотезы 03, не сохраняет отдельного эффекта при фиксированном ; в отличие от гипотезы 04, одиночные и проходят общий .

  • What would separate them

    Mitochondrial upkeep and senescent cell removal may jointly be required for longer life predicts: Из семи активных сочетаний общий проходят только + и ++; добавление к + не улучшает результат сверх заранее заданной . Ни , ни по отдельности не достигают даже при подтверждённом и при нескольких допустимых уровнях интенсивности. Специфическое выключение любого из двух процессов в успешной комбинации устраняет общий выигрыш, а его возврат восстанавливает выигрыш. Одиночная достаточность , ожидаемая в гипотезе 01, или самостоятельная достаточность , ожидаемая в гипотезах 02 и 03, опровергает этот набор.

What stands behind it

Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.

This hypothesis states no figure and cites no study, so there is nothing here to trace.

CitationsCites nothingFiguresnone statedPredictionWould tell it apart from at least one rivalTo refuteOnly a bench experiment would settle it

What it would take to refute it. Nothing already retrieved carries the prediction’s terms and it names no measurement this layer can route to a public dataset, so the bench is the residual — not a finding against it.

0 citation handles extracted; 1 Europe PMC search run; 0 records examined; 0 sources stored for enrichment, 0 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.